Literature DB >> 21208676

Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk 'Golden Years' type 1 diabetes cohort.

Sarah L Prior1, Danielle A Jones, Geoffrey V Gill, Steve C Bain, Jeffrey W Stephens.   

Abstract

The C-allele of rs266729 is associated with CHD, while the G-allele of rs17300539 is associated with metabolic traits. We examined these in type 1 diabetes. For rs266729, the C-allele was associated with 8-fold increase in CHD. For rs17300539, the G-allele was associated with increases in triglycerides and waist circumference.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208676     DOI: 10.1016/j.diabres.2010.12.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis.

Authors:  Huan Zhang; Xingbo Mo; Yongchen Hao; Dongfeng Gu
Journal:  BMC Med Genet       Date:  2012-05-28       Impact factor: 2.103

2.  Serum adiponectin and cortisol levels are not affected by studied ADIPOQ gene variants: Tehran lipid and glucose study.

Authors:  Masoumeh Nezhadali; Seyed Alireza Mesbah-Namin; Mehdi Hedayati; Mahdi Akbarzadeh; Leila Najd Hassan Bonab; Maryam S Daneshpour
Journal:  BMC Endocr Disord       Date:  2022-04-18       Impact factor: 3.263

3.  Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study.

Authors:  Joseph Sam Kanu; Yulu Gu; Sun Zhi; Mingxi Yu; Yuping Lu; Yetong Cong; Yunkai Liu; Yong Li; Yaqin Yu; Yi Cheng; Yawen Liu
Journal:  Lipids Health Dis       Date:  2016-01-12       Impact factor: 3.876

4.  Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.

Authors:  Johnny W Bai; Geneviève Boulet; Elise M Halpern; Leif E Lovblom; Devrim Eldelekli; Hillary A Keenan; Michael Brent; Narinder Paul; Vera Bril; David Z I Cherney; Alanna Weisman; Bruce A Perkins
Journal:  Cardiovasc Diabetol       Date:  2016-01-25       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.